Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020.

Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, Isenhour C, Clarke KR, Evans ME, Chu VT, Biggs HM, Kirking HL, Gerber SI, Hall AJ, Fry AM, Oliver SE; 2019-nCoV Persons Under Investigation Team; 2019-CoV Persons Under Investigation Team.

MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):166-170. doi: 10.15585/mmwr.mm6906e1.

2.

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.

Patel A, Jernigan DB; 2019-nCoV CDC Response Team.

MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1.

3.

An interim review of the epidemiological characteristics of 2019 novel coronavirus.

Ryu S, Chun BC; Korean Society of Epidemiology 2019-nCoV Task Force Team.

Epidemiol Health. 2020;42:e2020006. doi: 10.4178/epih.e2020006. Epub 2020 Feb 6. Review.

4.

Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study.

Park HC, Lee SH, Kim J, Kim DH, Cho A, Jeon HJ, Oh J, Noh JW, Jeong DW, Kim YG, Lee CH, Yoo KD, Lee YK.

Medicine (Baltimore). 2020 Jan;99(3):e18782. doi: 10.1097/MD.0000000000018782.

5.

Note from the editors: novel coronavirus (2019-nCoV).

Eurosurveillance Editorial Team.

Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2001231. No abstract available.

6.

Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.

Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, Cowling BJ, Leung GM.

Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000044.

7.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C.

Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.

8.

miR-142a-3p promotes the proliferation of porcine hemagglutinating encephalomyelitis virus by targeting Rab3a.

Fan P, Guan J, He W, Lv X, Hu S, Lan Y, Zhao K, Gao F, Li F, Fan G, He H, Li Z.

Arch Virol. 2020 Feb;165(2):345-354. doi: 10.1007/s00705-019-04470-z. Epub 2019 Dec 13.

PMID:
31834525
9.

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors.

Park YJ, Walls AC, Wang Z, Sauer MM, Li W, Tortorici MA, Bosch BJ, DiMaio F, Veesler D.

Nat Struct Mol Biol. 2019 Dec;26(12):1151-1157. doi: 10.1038/s41594-019-0334-7. Epub 2019 Dec 2.

PMID:
31792450
10.

The dynamics and interactions of respiratory pathogen carriage among French pilgrims during the 2018 Hajj.

Hoang VT, Dao TL, Ly TDA, Belhouchat K, Chaht KL, Gaudart J, Mrenda BM, Drali T, Yezli S, Alotaibi B, Fournier PE, Raoult D, Parola P, de Santi VP, Gautret P.

Emerg Microbes Infect. 2019;8(1):1701-1710. doi: 10.1080/22221751.2019.1693247.

11.

The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019.

Salamatbakhsh M, Mobaraki K, Sadeghimohammadi S, Ahmadzadeh J.

BMC Public Health. 2019 Nov 14;19(1):1523. doi: 10.1186/s12889-019-7899-2.

12.

Inhibition of SARS-CoV 3CL protease by flavonoids.

Jo S, Kim S, Shin DH, Kim MS.

J Enzyme Inhib Med Chem. 2020 Dec;35(1):145-151. doi: 10.1080/14756366.2019.1690480.

13.

Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.

Rodon J, Okba NMA, Te N, van Dieren B, Bosch BJ, Bensaid A, Segalés J, Haagmans BL, Vergara-Alert J.

Emerg Microbes Infect. 2019;8(1):1593-1603. doi: 10.1080/22221751.2019.1685912.

14.

Detecting Emerging Infectious Diseases: An Overview of the Laboratory Response Network for Biological Threats.

Villanueva J, Schweitzer B, Odle M, Aden T.

Public Health Rep. 2019 Nov/Dec;134(2_suppl):16S-21S. doi: 10.1177/0033354919874354. Erratum in: Public Health Rep. 2020 Jan;135(1):161.

PMID:
31682559
15.

Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

Habib AMG, Ali MAE, Zouaoui BR, Taha MAH, Mohammed BS, Saquib N.

BMC Infect Dis. 2019 Oct 22;19(1):870. doi: 10.1186/s12879-019-4555-5.

16.

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.

Chen D, Hou Z, Jiang D, Zheng M, Li G, Zhang Y, Li R, Lin H, Chang J, Zeng H, Guo JT, Zhao X.

Emerg Microbes Infect. 2019;8(1):1511-1523. doi: 10.1080/22221751.2019.1677446.

17.

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody.

Kim SI, Kim S, Kim J, Chang SY, Shim JM, Jin J, Lim C, Baek S, Min JY, Park WB, Oh MD, Kim S, Chung J.

Int J Mol Sci. 2019 Oct 12;20(20). pii: E5073. doi: 10.3390/ijms20205073.

18.

P200 family protein IFI204 negatively regulates type I interferon responses by targeting IRF7 in nucleus.

Cao L, Ji Y, Zeng L, Liu Q, Zhang Z, Guo S, Guo X, Tong Y, Zhao X, Li CM, Chen Y, Guo D.

PLoS Pathog. 2019 Oct 11;15(10):e1008079. doi: 10.1371/journal.ppat.1008079. eCollection 2019 Oct.

19.

Human virome in nasopharynx and tracheal secretion samples.

Souza LDC, Blawid R, Silva JMF, Nagata T.

Mem Inst Oswaldo Cruz. 2019 Oct 3;114:e190198. doi: 10.1590/0074-02760190198. eCollection 2019.

Supplemental Content

Loading ...
Support Center